What happened
On September 25, 2026, FDA published a Federal Register notice, document 2026-19658, at 91 FR 60911. The notice states that Doehler GmbH filed a color additive petition requesting that the agency amend the color additive regulations in 21 CFR 73. The requested amendment would provide for the safe use of calcium sulfate in various foods at levels consistent with good manufacturing practice. It identifies Docket No. FDA-2026-C-10597 and classifies the publication as a proposed rule. The filing notice says the color additive petition was filed. The excerpt provided does not include any decision by FDA on the petition.
Why it matters
This is an early regulatory step, not an approval. That distinction matters for ingredient manufacturers, branded food companies, and investors tracking formulation pipelines. FDA has formally logged the request and assigned it to the color additive framework under 21 CFR 73. The likely read is that companies exposed to food color systems will watch whether FDA moves from acknowledging the petition to proposing or finalizing a specific amendment. Until then, this is process, not commercialization clearance.
A broader signal sits behind the filing. Even a one-page notice can matter because it marks where suppliers are trying to expand permitted use cases under existing color additive regulations. If the petition advances, it could become a modest but tangible precedent for other ingredient sponsors considering similar submissions. For adjacent regulatory tracking, readers following ingredient and product-status developments can also see ClinicalRx.ai for reference-style coverage and RxNews.ai for broader drug and healthcare news context.
